Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Genentech presents new bicyclic-proline TRPA1 antagonists with improved physical properties

April 4, 2017

Arbutus licenses LNP technology to Alexion for use in rare disease program

March 17, 2017

Clarivate Analytics launches Drug Research Advisor with target identification app

March 16, 2017

CRISPR Therapeutics and Casebia sign commercial license agreement with MaxCyte

March 14, 2017

Pharnext and Galapagos collaborate to generate pipeline of synergistic drug combinations

March 10, 2017

Cellect Biotechnology reports positive final results from clinical trial of ApoGraft

Feb. 22, 2017

Small molecule UPC-K-005 acts through a novel inhibitory allosteric site in p38alpha

Feb. 20, 2017

Engineered plant cells allow protein delivery for tolerance induction for hemophilia treatment

Feb. 15, 2017

Marina Biotech signs licensing agreement for SMARTICLES platform

Feb. 8, 2017

Isogenica grants license to Maverick Therapeutics for antibody technology

Feb. 7, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...